Human IL-1 beta Recombinant Protein

Catalog Number:
RP0877H
Availability:
In stock
Application:
Cell Culture, ELISA Standard, ELISpot Control, Western Blot Control
100% Homology:
Homo sapiens (human), Pan paniscus (pygmy chimpanzee), Pan troglodytes (chimpanzee)
  • Human IL-1β (catalog RP0877H) is a yeast-derived cytokine supplied lyophilized without carrier protein in 10% trehalose; it has no affinity tags and is naturally endotoxin-free, and should be reconstituted in sterile PBS that contains at least 0.1% carrier protein. The protein is ~17.4 kDa, 153 amino acids long (full sequence provided), and >98% pure by SDS-PAGE, with 100% amino-acid homology to human, chimpanzee, and bonobo. Store at -20°C (stable up to twelve months from date of receipt; working aliquots with carrier protein stable ~3 months) and avoid repeated freeze/thaw cycles. Product origin is the USA. It is commonly used to study IL-1 signaling and inflammatory responses (including activation of immune cells and cytokine production); typical experimental uses include cell-culture stimulation and dosing studies, cytokine signaling assays, ELISA and neutralization assays, flow-cytometry and Western blot controls, and antibody generation/validation. Kingfisher Biotech products are supplied for research applications and are not intended for medicinal, diagnostic, or therapeutic use.
Amino Acid SequenceAPVRSLNCTL RDSQQKSLVM SGPYELKALH LQGQDMEQQV VFSMSFVQGE ESNDKIPVAL GLKEKNLYLS CVLKDDKPTL QLESVDPKNY PKKKMEKRFV FNKIEINNKL EFESAQFPNW YISTSQAENM PVFLGGTKGG QDITDFTMQF VSS (153)
EndotoxinNaturally endotoxin-free
Storage Conditions-20°C
Molecular Weight17.4 kDa
Purity>98% as visualized by SDS-PAGE analysis.
Country Of OriginUSA
  • Human Interleukin-1 Beta (IL-1β) is a potent pro-inflammatory cytokine produced primarily by activated macrophages, monocytes, and dendritic cells in response to infection, tissue injury, or danger-associated molecular patterns. Synthesized as an inactive precursor (pro-IL-1β), it is cleaved into its active form by caspase-1 within multiprotein inflammasome complexes-most notably the NLRP3 inflammasome-and subsequently signals through the IL-1 receptor type 1 (IL-1R1), activating NF-κB and MAPK pathways that drive fever, leukocyte recruitment, endothelial activation, and acute-phase protein production. IL-1β plays a central role in host defense against bacterial, viral, and fungal pathogens, but dysregulated or excessive IL-1β signaling contributes to a wide range of inflammatory and autoimmune conditions, including rheumatoid arthritis, gout, inflammatory bowel disease, type 2 diabetes, atherosclerosis, sepsis, and cytokine release syndromes. Elevated IL-1β is also implicated in neuroinflammatory disorders and certain cancers, where it can promote tumor progression and immune modulation. As both a biomarker and therapeutic target, IL-1β has been the focus of targeted biologic therapies such as IL-1 receptor antagonists and anti-IL-1β monoclonal antibodies. Consequently, human IL-1β is central to research on inflammasome biology, chronic inflammation, metabolic disease, and development of precision anti-inflammatory treatments.

Please choose a size to see price


Reagents for Animal Model and Animal Health Research

Kingfisher Biotech, Inc.
1000 Westgate Drive
Suite 123
Saint Paul, MN 55114

Phone: 651-646-0089
Fax: 651-646-0095

Animal Antibodies

Newsletter

"